{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:40:51Z","timestamp":1775040051106,"version":"3.50.1"},"reference-count":140,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T00:00:00Z","timestamp":1623628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Severe acute respiratory syndrome-coronavirus 2, a novel betacoronavirus, has caused the global outbreak of a contagious infection named coronavirus disease-2019. Severely ill subjects have shown higher levels of pro-inflammatory cytokines. Cytokine storm is the term that can be used for a systemic inflammation leading to the production of inflammatory cytokines and activation of immune cells. In coronavirus disease-2019 infection, a cytokine storm contributes to the mortality rate of the disease and can lead to multiple-organ dysfunction syndrome through auto-destructive responses of systemic inflammation. Direct effects of the severe acute respiratory syndrome associated with infection as well as hyperinflammatory reactions are in association with disease complications. Besides acute respiratory distress syndrome, functional impairments of the cardiovascular system, central nervous system, kidneys, liver, and several others can be mentioned as the possible consequences. In addition to the current therapeutic approaches for coronavirus disease-2019, which are mostly supportive, stem cell-based therapies have shown the capacity for controlling the inflammation and attenuating the cytokine storm. Therefore, after a brief review of novel coronavirus characteristics, this review aims to explain the effects of coronavirus disease-2019 cytokine storm on different organs of the human body. The roles of stem cell-based therapies on attenuating cytokine release syndrome are also stated.<\/jats:p>","DOI":"10.3389\/fcell.2021.675310","type":"journal-article","created":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T06:59:11Z","timestamp":1623653951000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions"],"prefix":"10.3389","volume":"9","author":[{"given":"Babak","family":"Arjmand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Alavi-Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyvand","family":"Parhizkar Roudsari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fakher","family":"Rahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambiz","family":"Gilany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereshteh","family":"Mohamadi-Jahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Adibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bagher","family":"Larijani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,14]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1186\/s13619-020-00058-0","article-title":"Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives.","volume":"9","author":"Abedi","year":"2020","journal-title":"Cell Regen."},{"key":"B2","article-title":"Clinical outcome of autologous mononuclear cells transplantation for spinal cord injury: a systematic review and meta-analysis.","volume":"28","author":"Aghayan","year":"","journal-title":"Med. J. Islam. Repub. Iran."},{"key":"B3","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/7651_2014_112","article-title":"GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy","author":"Aghayan","year":"","journal-title":"Stem Cells and Good Manufacturing Practices: Methods in Molecular Biology"},{"key":"B4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5527\/wjn.v9.i2.18","article-title":"Kidney injury in COVID-19.","volume":"9","author":"Ahmed","year":"2020","journal-title":"World J. Nephrol."},{"key":"B5","first-page":"771","article-title":"[Cytokine storm in the pathogenesis of multiple organ dysfunction syndrome associated with surgical insults].","volume":"97","author":"Aikawa","year":"1996","journal-title":"Nihon Geka Gakkai Zasshi"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01963-6","article-title":"Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.","volume":"11","author":"Al-Khawaga","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106116","article-title":"COVID-19 and the central nervous system.","volume":"198","author":"Alomari","year":"2020","journal-title":"Clin. Neurol. Neurosurg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/2050640620924157","article-title":"Liver injury in COVID-19: the current evidence.","volume":"8","author":"Alqahtani","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"B9","first-page":"321","article-title":"Gastrointestinal symptoms in patients with mild and severe COVID-19: a scoping review and meta-analysis.","volume":"13","author":"Arjmand","year":"2020","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00761","article-title":"Co-transplantation of human fetal mesenchymal and hematopoietic stem cells in type 1 diabetic mice model.","volume":"10","author":"Arjmand","year":"2019","journal-title":"Front. Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: a meta-analysis.","volume":"92","author":"Aziz","year":"2020","journal-title":"J. Med. Virol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.7454\/psr.v7i4.1092","article-title":"Cytokine storm in COVID-19: an overview, mechanism, treatment strategies, and stem cell therapy perspective.","volume":"7","author":"Azmi","year":"2020","journal-title":"Pharm. Sci. Res."},{"key":"B13","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/irv.12708","article-title":"Respiratory syncytial virus acute respiratory infection-associated hospitalizations in preterm Mexican infants: a cohort study.","volume":"14","author":"Ben\u00edtez-Guerra","year":"2020","journal-title":"Influenza Other Resp. Viruses"},{"key":"B14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13365-020-00840-5","article-title":"COVID-19 and the nervous system.","volume":"26","author":"Berger","year":"2020","journal-title":"J. Neurovirol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19\u2014immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper.","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy.","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.smim.2016.02.001","article-title":"Role of memory T cell subsets for adoptive immunotherapy.","volume":"28","author":"Busch","year":"2016","journal-title":"Semin. Immunol."},{"key":"B18","article-title":"Features, evaluation and treatment coronavirus (COVID-19)","author":"Cascella","year":"2020","journal-title":"StatPearls [Internet]"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02132","article-title":"Cytokine Storm in COVID-19: \u201cWhen You Come Out of the Storm, You Won\u2019t Be the Same Person Who Walked in\u201d.","volume":"11","author":"Castelli","year":"2020","journal-title":"Front. Immunol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00944","article-title":"Coronavirus disease (COVID-19\u2013SARS-CoV-2) and nutrition: is infection in Italy suggesting a connection?","volume":"11","author":"Cena","year":"2020","journal-title":"Front. Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1007\/s11684-019-0714-8","article-title":"Management of cytokine release syndrome related to CAR-T cell therapy.","volume":"13","author":"Chen","year":"2019","journal-title":"Front. Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104673","article-title":"The interplay between inflammatory pathways and COVID-19: a critical review on pathogenesis and therapeutic options.","volume":"150","author":"Choudhary","year":"2020","journal-title":"Microb. Pathogen."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1002\/cbin.11440","article-title":"Stem cell therapy for COVID-19: possibilities and challenges.","volume":"44","author":"Choudhery","year":"2020","journal-title":"Cell Biol. Int."},{"key":"B24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00281-020-00821-0","article-title":"Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population.","volume":"42","author":"Ciabattini","year":"2020","journal-title":"Semin. Immunopathol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.coi.2018.03.013","article-title":"Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering.","volume":"51","author":"Daher","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"B26","article-title":"Central nervous system manifestations associated with COVID-19.","volume":"20","author":"Divani","year":"2020","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110678","article-title":"ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19.","volume":"131","author":"Dong","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.602183","article-title":"The role of MSC therapy in attenuating the damaging effects of the cytokine storm induced by COVID-19 on the heart and cardiovascular system.","volume":"7","author":"Ellison-Hughes","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"B29","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm.","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200160","article-title":"Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines.","volume":"10","author":"Fara","year":"2020","journal-title":"Open Biol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.620730","article-title":"SARS-CoV-2-specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking, and large-scale production for adoptive cell therapy.","volume":"9","author":"Ferreras","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41565-020-0732-3","article-title":"Immune-mediated approaches against COVID-19.","volume":"15","author":"Florindo","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/joim.13144","article-title":"Cytokine storm syndrome in coronavirus disease 2019: a narrative review.","volume":"289","author":"Gao","year":"2021","journal-title":"J. Internal Med."},{"key":"B34","article-title":"Stem cell-based approach for the treatment of Parkinson\u2019s disease.","volume":"29","author":"Goodarzi","year":"2015","journal-title":"Med. J. Islam. Repub. Iran."},{"key":"B35","first-page":"651","article-title":"Stem cell therapy for treatment of epilepsy.","volume":"52","author":"Goodarzi","year":"2014","journal-title":"Acta Med. Iran."},{"key":"B36","first-page":"133","article-title":"Adipose tissue-derived stromal cells for wound healing","author":"Goodarzi","year":"","journal-title":"Cell Biology and Translational Medicine"},{"key":"B37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10561-018-9741-y","article-title":"Therapeutic abortion and ectopic pregnancy: alternative sources for fetal stem cell research and therapy in Iran as an Islamic country.","volume":"20","author":"Goodarzi","year":"2019","journal-title":"Cell Tissue Bank."},{"key":"B38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/5584_2018_251","article-title":"Mesenchymal stem cells-derived exosomes for wound regeneration","author":"Goodarzi","year":"","journal-title":"Cell Biology and Translational Medicine: Advances in Experimental Medicine and Biology"},{"key":"B39","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor\u2013modified T cells for acute lymphoid leukemia.","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Eng. J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s13577-020-00407-w","article-title":"Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.","volume":"33","author":"Gupta","year":"2020","journal-title":"Hum. Cell"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/bjh.16780","article-title":"Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.","volume":"189","author":"Hanley","year":"2020","journal-title":"Br. J. Haematol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1056\/nejme2018629","article-title":"Covid-19, angiogenesis, and ARDS endotypes.","volume":"383","author":"Hariri","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","article-title":"Mechanisms of SARS-CoV-2 transmission and pathogenesis.","volume":"41","author":"Harrison","year":"2020","journal-title":"Trends Immunol."},{"key":"B44","article-title":"Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment.","volume":"12","author":"Hassan","year":"2020","journal-title":"Cureus"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.2450","article-title":"Coronavirus disease 2019 (COVID-19) and cardiac injury.","volume":"5","author":"Heffernan","year":"2020","journal-title":"JAMA Cardiol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19.","volume":"72","author":"Henderson","year":"2020","journal-title":"Arthr. Rheumatol."},{"key":"B47","author":"Henriksen","year":"2020","journal-title":"Anti-il6 Treatment of Serious COVID-19 Disease with Threatening Respiratory Failure (TOCIVID)."},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1186\/s41232-020-00146-3","article-title":"How COVID-19 induces cytokine storm with high mortality.","volume":"40","author":"Hojyo","year":"2020","journal-title":"Inflamm. Regen."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.627764","article-title":"Biomarkers for chimeric antigen receptor T cell therapy in acute lymphoblastic leukemia: prospects for personalized management and prognostic prediction.","volume":"12","author":"Hong","year":"2021","journal-title":"Front. Immunol."},{"key":"B50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19.","volume":"19","author":"Hu","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"B51","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cell.2020.08.028","article-title":"Effects of COVID-19 on the nervous system.","volume":"183","author":"Iadecola","year":"","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1172\/jci135530","article-title":"Immune responses to stroke: mechanisms, modulation, and therapeutic potential.","volume":"130","author":"Iadecola","year":"","journal-title":"J. Clin. Investig."},{"key":"B53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000509483","article-title":"Weathering the cytokine storm in COVID-19: therapeutic implications.","volume":"10","author":"Iannaccone","year":"2020","journal-title":"Cardio. Med."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.166014","article-title":"Fostering mesenchymal stem cell therapy to halt cytokine storm in COVID-19.","volume":"1867","author":"Jeyaraman","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B55","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01849-7","article-title":"The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm.","volume":"11","author":"Kavianpour","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1182\/blood.2020008488","article-title":"SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein.","volume":"136","author":"Keller","year":"2020","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-020-01415-w","article-title":"Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.","volume":"17","author":"Khadke","year":"2020","journal-title":"Virol. J."},{"key":"B58","first-page":"e00542","article-title":"The non-structural protein NSs of SFTSV causes cytokine storm through the hyper-activation of NF-\u03baB.","volume":"41","author":"Khalil","year":"2020","journal-title":"Mol. Cell. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/0929866528666210222150347","article-title":"Mesenchymal stem cell derived-exosomes as effective factors in reducing cytokine storm symptoms of COVID-19.","author":"Kheirkhah","year":"2021","journal-title":"Protein Pept. Lett."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19.","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxab011","article-title":"Interleukin-6: from arthritis to CAR-T-cell therapy and COVID-19.","author":"Kishimoto","year":"2021","journal-title":"Int. Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1097\/meg.0000000000001806","article-title":"Case series and review of liver dysfunction in COVID-19 patients.","volume":"32","author":"Kudaravalli","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/07853890.2020.1790643","article-title":"Renal complications in COVID-19: a systematic review and meta-analysis.","volume":"52","author":"Kunutsor","year":"2020","journal-title":"Ann. Med."},{"key":"B64","first-page":"540","article-title":"Clinical grade human adipose tissue-derived mesenchymal stem cell banking.","volume":"53","author":"Larijani","year":"2015","journal-title":"Acta Med. Iran."},{"key":"B65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/7651_2014_101","article-title":"GMP-grade human fetal liver-derived mesenchymal stem cells for clinical transplantation","author":"Larijani","year":"2014","journal-title":"Stem Cells and Good Manufacturing Practices"},{"key":"B66","first-page":"1","article-title":"Stem cell-based models and therapies: a key approach into schizophrenia treatment.","author":"Larijani","year":"2021","journal-title":"Cell Tissue Bank."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/sctm.20-0239","article-title":"Mesenchymal stromal cells for sepsis and septic shock: lessons for treatment of COVID-19.","volume":"9","author":"Laroye","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cellimm.2017.08.009","article-title":"Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.","volume":"326","author":"Lee","year":"2018","journal-title":"Cell. Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome.","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.14336\/ad.2020.0228","article-title":"Transplantation of ACE2-mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia.","volume":"11","author":"Leng","year":"2020","journal-title":"Aging Dis."},{"key":"B71","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development.","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"B72","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012421","article-title":"The potential role of IL-6 in monitoring coronavirus disease 2019.","volume":"12","author":"Liu","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.cca.2020.05.044","article-title":"COVID-19: transmission, prevention, and potential therapeutic opportunities.","volume":"508","author":"Lotfi","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"B74","doi-asserted-by":"publisher","first-page":"14452","DOI":"10.1073\/pnas.1508520112","article-title":"Regenerative medicine: current therapies and future directions.","volume":"112","author":"Mao","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01512","article-title":"Flattening the COVID-19 curve with natural killer cell based immunotherapies.","volume":"11","author":"Market","year":"2020","journal-title":"Front. Immunol."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.583017","article-title":"Cell-free therapies: novel approaches for COVID-19.","volume":"11","author":"Maron-Gutierrez","year":"2020","journal-title":"Front. Immunol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/d41586-020-02599-5","article-title":"How COVID-19 can damage the brain.","volume":"585","author":"Marshall","year":"2020","journal-title":"Nature"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/sctm.19-0044","article-title":"Challenges in clinical development of mesenchymal stromal\/stem cells: concise review.","volume":"8","author":"Mastrolia","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"B79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-pathol-011110-130158","article-title":"The acute respiratory distress syndrome: pathogenesis and treatment.","volume":"6","author":"Matthay","year":"2011","journal-title":"Ann. Rev. Pathol. Mech. Dis."},{"key":"B80","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-immunol-032713-120136","article-title":"Adoptive immunotherapy for cancer or viruses.","volume":"32","author":"Maus","year":"2014","journal-title":"Ann. Rev. Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1634\/theoncologist.2015-0421","article-title":"Chimeric antigen receptor T-cell therapy for the community oncologist.","volume":"21","author":"Maus","year":"2016","journal-title":"Oncologist"},{"key":"B82","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.hrtlng.2020.04.019","article-title":"A review of cardiac manifestations and predictors of outcome in patients with COVID \u2013 19.","volume":"49","author":"Mishra","year":"2020","journal-title":"Heart Lung"},{"key":"B83","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10735-020-09915-3","article-title":"COVID-19 and multiorgan failure: a narrative review on potential mechanisms.","volume":"51","author":"Mokhtari","year":"2020","journal-title":"J. Mol. Histol."},{"key":"B84","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/ALN.0000000000000446","article-title":"Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.","volume":"121","author":"Monsel","year":"2014","journal-title":"Anesthesiology"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118166","article-title":"The pathophysiology of SARS-CoV-2: a suggested model and therapeutic approach.","volume":"258","author":"Morris","year":"2020","journal-title":"Life Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2020.03.001","article-title":"The novel coronavirus 2019 epidemic and kidneys.","volume":"97","author":"Naicker","year":"2020","journal-title":"Kidney Int."},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00051","article-title":"Overcoming resistance to natural killer cell based immunotherapies for solid tumors.","volume":"9","author":"Nayyar","year":"2019","journal-title":"Front. Oncol."},{"key":"B88","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-020-03120-0","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.","volume":"24","author":"Ni","year":"2020","journal-title":"Crit. Care"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s10072-020-04486-3","article-title":"The neurological manifestations of COVID-19: a review article.","volume":"41","author":"Niazkar","year":"2020","journal-title":"Neurol. Sci."},{"key":"B90","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1093\/gerona\/glaa209","article-title":"Underlying vulnerabilities to the cytokine storm and adverse COVID-19 outcomes in the aging immune system.","volume":"76","author":"Nidadavolu","year":"2020","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s00134-020-06026-1","article-title":"Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis","volume":"46","author":"Pan","year":"2020","journal-title":"Intensive Care Med."},{"key":"B92","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10561-020-09842-3","article-title":"Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.","volume":"21","author":"Parhizkar Roudsari","year":"2020","journal-title":"Cell Tissue Bank."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2020.101831","article-title":"The kidney and COVID-19 patients \u2013 important considerations.","volume":"37","author":"Patel","year":"2020","journal-title":"Travel Med. Infect. Dis."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/5584_2018_227","article-title":"Stem cell and obesity: current state and future perspective","author":"Payab","year":"2018","journal-title":"Cell Biology and Translational Medicine: Advances in Experimental Medicine and Biology"},{"key":"B95","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc2011400","article-title":"Multiorgan and renal tropism of SARS-CoV-2.","volume":"383","author":"Puelles","year":"2020","journal-title":"N. Eng. J. Med."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2020.e00467","article-title":"Combating COVID-19 with mesenchymal stem cell therapy.","volume":"26","author":"Rajarshi","year":"2020","journal-title":"Biotechnol. Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1038\/s41375-020-0887-9","article-title":"CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine \u201cstorm\u201d and risk factor for damage of hematopoietic stem cells.","volume":"34","author":"Ratajczak","year":"2020","journal-title":"Leukemia"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242127","article-title":"COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in Germany.","volume":"15","author":"Rieg","year":"2020","journal-title":"PLoS One"},{"key":"B99","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(20)30229-0","article-title":"Management of acute kidney injury in patients with COVID-19.","volume":"8","author":"Ronco","year":"2020","journal-title":"Lancet Resp. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-030-22094-5_4","article-title":"Laboratory features and pathology of the cytokine storm syndromes","author":"Rosado","year":"2019","journal-title":"Cytokine Storm Syndrome"},{"key":"B101","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neulet.2008.07.041","article-title":"Treatment of chronic thoracic spinal cord injury patients with autologous Schwann cell transplantation: an interim report on safety considerations and possible outcomes.","volume":"443","author":"Saberi","year":"2008","journal-title":"Neurosci. Lett."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jcyt.2016.09.003","article-title":"Genetically modified mesenchymal stromal cells in cancer therapy.","volume":"18","author":"Sage","year":"2016","journal-title":"Cytotherapy"},{"key":"B103","first-page":"1","article-title":"2019 Novel Coronavirus (COVID-19) Outbreak: a review of the current literature.","volume":"4","author":"Sahin","year":"2020","journal-title":"EJMO."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02711","article-title":"CAR T cells beyond cancer: hope for immunomodulatory therapy of infectious diseases.","volume":"10","author":"Seif","year":"2019","journal-title":"Front. Immunol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.bja.2020.08.050","article-title":"COVID-19 related organ dysfunction and management strategies on the intensive care unit.","volume":"125","author":"Sherren","year":"2020","journal-title":"Br. J. Anaes."},{"key":"B106","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/stem.3354","article-title":"Mesenchymal stem cell immunomodulation: in pursuit of controlling COVID-19 related cytokine storm.","volume":"39","author":"Song","year":"2021","journal-title":"Stem Cells"},{"key":"B107","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2.","volume":"509","author":"Song","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02182-2020","article-title":"Potential of regulatory T-cell-based therapies in the management of severe COVID-19.","volume":"56","author":"Stephen-Victor","year":"2020","journal-title":"Eur. Resp. J."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/liv.14470","article-title":"COVID-19 and liver disease.","volume":"40","author":"Sun","year":"2020","journal-title":"Liver Int."},{"key":"B110","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/jmv.25735","article-title":"Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: a single arm meta-analysis.","volume":"92","author":"Sun","year":"2020","journal-title":"J. Med. Virol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.cytogfr.2020.04.002","article-title":"Cytokine storm intervention in the early stages of COVID-19 pneumonia.","volume":"53","author":"Sun","year":"2020","journal-title":"Cytokine Growth Fact. Rev."},{"key":"B112","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.570993","article-title":"Controlling cytokine storm is vital in COVID-19.","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies.","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention.","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Reviews Immunol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s11033-020-06126-7","article-title":"Cellular therapy for treatment of spinal cord injury in Zebrafish model.","volume":"48","author":"Tayanloo-Beik","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"B117","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa1406761","article-title":"Clinical features and outcomes of Takotsubo (stress) cardiomyopathy.","volume":"373","author":"Templin","year":"2015","journal-title":"N. Eng. J. Med."},{"key":"B118","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm.","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02049-2020","article-title":"Pathogenesis of COVID-19-induced ARDS: implications for an ageing population.","volume":"56","author":"Torres Acosta","year":"2020","journal-title":"Eur. Resp. J."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118482","article-title":"Cardiac inflammation in COVID-19: lessons from heart failure.","volume":"260","author":"Unudurthi","year":"2020","journal-title":"Life Sci."},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176351","article-title":"Natural killer cell dysfunction and its role in COVID-19.","volume":"21","author":"van Eeden","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B122","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ijid.2020.04.061","article-title":"Mild versus severe COVID-19: laboratory markers.","volume":"95","author":"Velavan","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00631","article-title":"The rise of allogeneic natural killer cells as a platform for cancer immunotherapy: recent innovations and future developments.","volume":"8","author":"Veluchamy","year":"2017","journal-title":"Front. Immunol."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118510","article-title":"Pharmacological agents to therapeutic treatment of cardiac injury caused by Covid-19.","volume":"262","author":"Vitiello","year":"2020","journal-title":"Life Sci."},{"key":"B125","doi-asserted-by":"crossref","DOI":"10.1186\/s43066-021-00082-y","article-title":"The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced.","volume":"11","author":"Vitiello","year":"2021","journal-title":"Egypt. Liver J."},{"key":"B126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein.","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B127","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ajem.2007.10.031","article-title":"The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome.","volume":"26","author":"Wang","year":"2008","journal-title":"Am. J. Emerg. Med."},{"key":"B128","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720965980","article-title":"Stem cell transplantation therapy: a potential method for treating cytokine storm syndromes induced by COVID-19.","volume":"29","author":"Wang","year":"2020","journal-title":"Cell Transpl."},{"key":"B129","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3057624","article-title":"Mesenchymal stem cell-based immunomodulation: properties and clinical application.","volume":"2018","author":"Wang","year":"2018","journal-title":"Stem Cells Int."},{"key":"B130","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jmv.25748","article-title":"Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.","volume":"92","author":"Wang","year":"2020","journal-title":"J. Med. Virol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.biotechadv.2012.11.006","article-title":"Enabling stem cell therapies for tissue repair: current and future challenges.","volume":"31","author":"Wong","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.3748\/wjg.v26.i19.2286","article-title":"Liver diseases in COVID-19: etiology, treatment and prognosis.","volume":"26","author":"Wu","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"874","DOI":"10.14336\/ad.2020.0520","article-title":"Multi-organ dysfunction in patients with COVID-19: a systematic review and meta-analysis.","volume":"11","author":"Wu","year":"2020","journal-title":"Aging Dis."},{"key":"B134","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-020-01804-6","article-title":"Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.","volume":"11","author":"Xiao","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"B135","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-020-01369-z","article-title":"SARS-CoV-2: characteristics and current advances in research.","volume":"17","author":"Yang","year":"2020","journal-title":"Virol. J."},{"key":"B136","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of theCytokine Storm\u2019in COVID-19.","volume":"80","author":"Ye","year":"2020","journal-title":"J. Infect."},{"key":"B137","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and multi-organ response.","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr. Prob. Cardiol."},{"key":"B138","first-page":"367","article-title":"Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach.","volume":"13","author":"Zamanian Azodi","year":"2020","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"B139","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ijid.2020.04.086","article-title":"Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a systemic review and meta-analysis.","volume":"96","author":"Zhao","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2020.557652","article-title":"Transplantation of mesenchymal stem cells: a potential adjuvant therapy for COVID-19.","volume":"8","author":"Zhu","year":"2020","journal-title":"Front. Bioeng. Biotechnol."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.675310\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,31]],"date-time":"2022-12-31T00:44:49Z","timestamp":1672447489000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.675310\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,14]]},"references-count":140,"alternative-id":["10.3389\/fcell.2021.675310"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.675310","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,14]]},"article-number":"675310"}}